Abstract
The hypoxic cell radiosensitizer, Ro 07-0582, has now been given in multiple doses to 16 patients. They have received a total of 15-51 g in 3-20 doses. Immediate tolerance was good, and satisfactory plasma levels of the drug were consistently obtained. Neurotoxicity was, however, troublesome: convulsions occurred in the patient given the highest dose, and there was peripheral neuropathy in 11 cases. Tumour concentrations similar to those in plasma were obtained in human tumours, in contrast to the findings in mouse tumours where concentrations are usually below 40% of plasma levels. In the treatment of human tumours, a lower dose of Ro 07-0582 should give useful hypoxic cell sensitization. Although the total dose of Ro 07-0582 must be limited, there is a real prospect that it will give benefit in clinical radiotherapy.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adams G. E., Flockhart I. R., Smithen C. E., Stratford I. J., Wardman P., Watts M. E. Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res. 1976 Jul;67(1):9–20. [PubMed] [Google Scholar]
- Choi C. H., Suit H. D. Evaluation of rapid radiation treatment schedules utilizing two treatment sessions per day. Radiology. 1975 Sep;116(3):703–707. doi: 10.1148/116.3.703. [DOI] [PubMed] [Google Scholar]
- Coxon A., Pallis C. A. Metronidazole neuropathy. J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):403–405. doi: 10.1136/jnnp.39.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dische S., Gray A. J., Zanelli G. D. Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin. Clin Radiol. 1976 Apr;27(2):159–166. doi: 10.1016/s0009-9260(76)80138-9. [DOI] [PubMed] [Google Scholar]
- Dische S., Senanayake F. Radiotherapy using hyperbaric oxygen in the palliation of carcinoma of colon and rectum. Clin Radiol. 1972 Oct;23(4):512–518. doi: 10.1016/s0009-9260(72)80032-1. [DOI] [PubMed] [Google Scholar]
- Foster J. L., Flockhart I. R., Dische S., Gray A., Lenox-Smith I., Smithen C. E. Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results. Br J Cancer. 1975 Jun;31(6):679–683. doi: 10.1038/bjc.1975.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gray A. J., Dische S., Adams G. E., Flockhart I. R., Foster J. L. Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. Clin Radiol. 1976 Apr;27(2):151–157. doi: 10.1016/s0009-9260(76)80137-7. [DOI] [PubMed] [Google Scholar]
- Ingham H. R., Selkon J. B., Hale J. H. The antibacterial activity of netronidazole. J Antimicrob Chemother. 1975 Dec;1(4):355–361. doi: 10.1093/jac/1.4.355. [DOI] [PubMed] [Google Scholar]
- Johnson R., Gomer C., Ambrus J., Pearce J., Boyle D. Letter: An investigation of the pharmacological and radiosensitizing effects of the 2-nitroimidazole Ro-07-0582 in primates. Br J Radiol. 1976 Mar;49(579):294–295. doi: 10.1259/0007-1285-49-579-294-b. [DOI] [PubMed] [Google Scholar]
- Svoboda V. H. Radiotherapy by several sessions a day. Br J Radiol. 1975 Feb;48(566):131–133. doi: 10.1259/0007-1285-48-566-131. [DOI] [PubMed] [Google Scholar]
- Thomlinson R. H., Dische S., Gray A. J., Errington L. M. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol. 1976 Apr;27(2):167–174. doi: 10.1016/s0009-9260(76)80139-0. [DOI] [PubMed] [Google Scholar]
- Urtasun R., Band P., Chapman J. D., Feldstein M. L., Mielke B., Fryer C. Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med. 1976 Jun 17;294(25):1364–1367. doi: 10.1056/NEJM197606172942503. [DOI] [PubMed] [Google Scholar]